Specifically, if FAM46C can be induced downstream of specific receptor engagement, as demonstrated by Bilska and colleagues [71], it would be tempting to speculate to improve cancer patient therapy by up-modulating FAM46C protein levels through simple receptor activation. Here, TENT5C is linked to cancer.